PDE4B inhibitor (Tetra Therapeutics)

N/A

Report date: 2024/04/28 17:06:39
NME

Base Information

Drug NamePDE4B inhibitor (Tetra Therapeutics)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionPhosphodiesterase 4B inhibitors
TargetsPhosphodiesterase 4B
Therapy Area/IndicationsAlzheimer DiseaseChronic Traumatic EncephalopathyMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTetra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTetra Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseChronic Traumatic EncephalopathyMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A